Serveur d'exploration sur le saule

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.

Identifieur interne : 001149 ( Main/Exploration ); précédent : 001148; suivant : 001150

Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.

Auteurs : Barry K. Logan [Oman] ; Amanda L A. Mohr [États-Unis] ; Stephen K. Talpins [États-Unis]

Source :

RBID : pubmed:24894458

Descripteurs français

English descriptors

Abstract

The use of oral fluid (OF) drug testing devices offers the ability to rapidly obtain a drug screening result at the time of a traffic stop. We describe an evaluation of two such devices, the Dräger Drug Test 5000 and the Affiniton DrugWipe, to detect drug use in a cohort of drivers arrested from an investigation of drug impaired driving (n = 92). Overall, 41% of these drivers were ultimately confirmed positive by mass spectrometry for the presence of one or more drugs. The most frequently detected drugs were cannabinoids (30%), benzodiazepines (11%) and cocaine (10%). Thirty-nine percent of drivers with blood alcohol concentrations >0.08 g/100 mL were found to be drug positive. Field test results obtained from OF samples were compared with collected OF and urine samples subsequently analyzed in the laboratory by gas or liquid chromatography-mass spectrometry. The Dräger Drug Test 5000 (DDT5000) and DrugWipe returned overall sensitivities of 51 and 53%, and positive predictive values of 93 and 63%, respectively. The most notable difference in performance was the DDT5000's better sensitivity in detecting marijuana use. Both devices failed to detect benzodiazepine use. Oral fluid proved to be a more effective confirmatory specimen, with more drugs being confirmed in OF than urine.

DOI: 10.1093/jat/bku050
PubMed: 24894458


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.</title>
<author>
<name sortKey="Logan, Barry K" sort="Logan, Barry K" uniqKey="Logan B" first="Barry K" last="Logan">Barry K. Logan</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Center for Forensic Science Research and Education, Willow Grove, PA, USA NMS Labs, Willow Grove, PA, USA Barry.Logan@nmslabs.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>The Center for Forensic Science Research and Education, Willow Grove, PA, USA NMS Labs, Willow Grove, PA</wicri:regionArea>
<wicri:noRegion>PA</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mohr, Amanda L A" sort="Mohr, Amanda L A" uniqKey="Mohr A" first="Amanda L A" last="Mohr">Amanda L A. Mohr</name>
<affiliation wicri:level="2">
<nlm:affiliation>The Center for Forensic Science Research and Education, Willow Grove, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Center for Forensic Science Research and Education, Willow Grove, PA</wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Talpins, Stephen K" sort="Talpins, Stephen K" uniqKey="Talpins S" first="Stephen K" last="Talpins">Stephen K. Talpins</name>
<affiliation wicri:level="2">
<nlm:affiliation>Institute for Behavior and Health Inc., Rockville, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Institute for Behavior and Health Inc., Rockville, MD</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24894458</idno>
<idno type="pmid">24894458</idno>
<idno type="doi">10.1093/jat/bku050</idno>
<idno type="wicri:Area/Main/Corpus">001103</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001103</idno>
<idno type="wicri:Area/Main/Curation">001103</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001103</idno>
<idno type="wicri:Area/Main/Exploration">001103</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.</title>
<author>
<name sortKey="Logan, Barry K" sort="Logan, Barry K" uniqKey="Logan B" first="Barry K" last="Logan">Barry K. Logan</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Center for Forensic Science Research and Education, Willow Grove, PA, USA NMS Labs, Willow Grove, PA, USA Barry.Logan@nmslabs.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>The Center for Forensic Science Research and Education, Willow Grove, PA, USA NMS Labs, Willow Grove, PA</wicri:regionArea>
<wicri:noRegion>PA</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mohr, Amanda L A" sort="Mohr, Amanda L A" uniqKey="Mohr A" first="Amanda L A" last="Mohr">Amanda L A. Mohr</name>
<affiliation wicri:level="2">
<nlm:affiliation>The Center for Forensic Science Research and Education, Willow Grove, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Center for Forensic Science Research and Education, Willow Grove, PA</wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Talpins, Stephen K" sort="Talpins, Stephen K" uniqKey="Talpins S" first="Stephen K" last="Talpins">Stephen K. Talpins</name>
<affiliation wicri:level="2">
<nlm:affiliation>Institute for Behavior and Health Inc., Rockville, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Institute for Behavior and Health Inc., Rockville, MD</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of analytical toxicology</title>
<idno type="eISSN">1945-2403</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Automobile Driving (legislation & jurisprudence)</term>
<term>Cohort Studies (MeSH)</term>
<term>Crime (MeSH)</term>
<term>Equipment Design (MeSH)</term>
<term>Female (MeSH)</term>
<term>Florida (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Illicit Drugs (analysis)</term>
<term>Illicit Drugs (urine)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Reproducibility of Results (MeSH)</term>
<term>Saliva (chemistry)</term>
<term>Sensitivity and Specificity (MeSH)</term>
<term>Specimen Handling (MeSH)</term>
<term>Substance Abuse Detection (instrumentation)</term>
<term>Substance Abuse Detection (methods)</term>
<term>Substance-Related Disorders (diagnosis)</term>
<term>Substance-Related Disorders (epidemiology)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Conception d'appareillage (MeSH)</term>
<term>Conduite automobile (législation et jurisprudence)</term>
<term>Crime (MeSH)</term>
<term>Détection d'abus de substances (instrumentation)</term>
<term>Détection d'abus de substances (méthodes)</term>
<term>Femelle (MeSH)</term>
<term>Floride (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Manipulation d'échantillons (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Reproductibilité des résultats (MeSH)</term>
<term>Salive (composition chimique)</term>
<term>Sensibilité et spécificité (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Troubles liés à une substance (diagnostic)</term>
<term>Troubles liés à une substance (épidémiologie)</term>
<term>Études de cohortes (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Illicit Drugs</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="urine" xml:lang="en">
<term>Illicit Drugs</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Florida</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Saliva</term>
</keywords>
<keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr">
<term>Salive</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Troubles liés à une substance</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="instrumentation" xml:lang="en">
<term>Substance Abuse Detection</term>
</keywords>
<keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en">
<term>Automobile Driving</term>
</keywords>
<keywords scheme="MESH" qualifier="législation et jurisprudence" xml:lang="fr">
<term>Conduite automobile</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Substance Abuse Detection</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr">
<term>Détection d'abus de substances</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Détection d'abus de substances</term>
<term>Troubles liés à une substance</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Cohort Studies</term>
<term>Crime</term>
<term>Equipment Design</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Reproducibility of Results</term>
<term>Sensitivity and Specificity</term>
<term>Specimen Handling</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Conception d'appareillage</term>
<term>Crime</term>
<term>Femelle</term>
<term>Floride</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Manipulation d'échantillons</term>
<term>Mâle</term>
<term>Reproductibilité des résultats</term>
<term>Sensibilité et spécificité</term>
<term>Sujet âgé</term>
<term>Études de cohortes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The use of oral fluid (OF) drug testing devices offers the ability to rapidly obtain a drug screening result at the time of a traffic stop. We describe an evaluation of two such devices, the Dräger Drug Test 5000 and the Affiniton DrugWipe, to detect drug use in a cohort of drivers arrested from an investigation of drug impaired driving (n = 92). Overall, 41% of these drivers were ultimately confirmed positive by mass spectrometry for the presence of one or more drugs. The most frequently detected drugs were cannabinoids (30%), benzodiazepines (11%) and cocaine (10%). Thirty-nine percent of drivers with blood alcohol concentrations >0.08 g/100 mL were found to be drug positive. Field test results obtained from OF samples were compared with collected OF and urine samples subsequently analyzed in the laboratory by gas or liquid chromatography-mass spectrometry. The Dräger Drug Test 5000 (DDT5000) and DrugWipe returned overall sensitivities of 51 and 53%, and positive predictive values of 93 and 63%, respectively. The most notable difference in performance was the DDT5000's better sensitivity in detecting marijuana use. Both devices failed to detect benzodiazepine use. Oral fluid proved to be a more effective confirmatory specimen, with more drugs being confirmed in OF than urine. </div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">24894458</PMID>
<DateCompleted>
<Year>2015</Year>
<Month>04</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1945-2403</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>38</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Journal of analytical toxicology</Title>
<ISOAbbreviation>J Anal Toxicol</ISOAbbreviation>
</Journal>
<ArticleTitle>Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.</ArticleTitle>
<Pagination>
<MedlinePgn>444-50</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/jat/bku050</ELocationID>
<Abstract>
<AbstractText>The use of oral fluid (OF) drug testing devices offers the ability to rapidly obtain a drug screening result at the time of a traffic stop. We describe an evaluation of two such devices, the Dräger Drug Test 5000 and the Affiniton DrugWipe, to detect drug use in a cohort of drivers arrested from an investigation of drug impaired driving (n = 92). Overall, 41% of these drivers were ultimately confirmed positive by mass spectrometry for the presence of one or more drugs. The most frequently detected drugs were cannabinoids (30%), benzodiazepines (11%) and cocaine (10%). Thirty-nine percent of drivers with blood alcohol concentrations >0.08 g/100 mL were found to be drug positive. Field test results obtained from OF samples were compared with collected OF and urine samples subsequently analyzed in the laboratory by gas or liquid chromatography-mass spectrometry. The Dräger Drug Test 5000 (DDT5000) and DrugWipe returned overall sensitivities of 51 and 53%, and positive predictive values of 93 and 63%, respectively. The most notable difference in performance was the DDT5000's better sensitivity in detecting marijuana use. Both devices failed to detect benzodiazepine use. Oral fluid proved to be a more effective confirmatory specimen, with more drugs being confirmed in OF than urine. </AbstractText>
<CopyrightInformation>© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Logan</LastName>
<ForeName>Barry K</ForeName>
<Initials>BK</Initials>
<AffiliationInfo>
<Affiliation>The Center for Forensic Science Research and Education, Willow Grove, PA, USA NMS Labs, Willow Grove, PA, USA Barry.Logan@nmslabs.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mohr</LastName>
<ForeName>Amanda L A</ForeName>
<Initials>AL</Initials>
<AffiliationInfo>
<Affiliation>The Center for Forensic Science Research and Education, Willow Grove, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Talpins</LastName>
<ForeName>Stephen K</ForeName>
<Initials>SK</Initials>
<AffiliationInfo>
<Affiliation>Institute for Behavior and Health Inc., Rockville, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>06</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Anal Toxicol</MedlineTA>
<NlmUniqueID>7705085</NlmUniqueID>
<ISSNLinking>0146-4760</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013287">Illicit Drugs</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Anal Toxicol. 2015 May;39(4):332-3</RefSource>
<PMID Version="1">25698776</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Anal Toxicol. 2015 May;39(4):330-1</RefSource>
<PMID Version="1">25698778</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001334" MajorTopicYN="N">Automobile Driving</DescriptorName>
<QualifierName UI="Q000331" MajorTopicYN="Y">legislation & jurisprudence</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003415" MajorTopicYN="Y">Crime</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005431" MajorTopicYN="N" Type="Geographic">Florida</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013287" MajorTopicYN="N">Illicit Drugs</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
<QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012463" MajorTopicYN="N">Saliva</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013048" MajorTopicYN="N">Specimen Handling</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015813" MajorTopicYN="Y">Substance Abuse Detection</DescriptorName>
<QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019966" MajorTopicYN="Y">Substance-Related Disorders</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>6</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>6</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>4</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24894458</ArticleId>
<ArticleId IdType="pii">bku050</ArticleId>
<ArticleId IdType="doi">10.1093/jat/bku050</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Oman</li>
<li>États-Unis</li>
</country>
<region>
<li>Maryland</li>
<li>Pennsylvanie</li>
</region>
</list>
<tree>
<country name="Oman">
<noRegion>
<name sortKey="Logan, Barry K" sort="Logan, Barry K" uniqKey="Logan B" first="Barry K" last="Logan">Barry K. Logan</name>
</noRegion>
</country>
<country name="États-Unis">
<region name="Pennsylvanie">
<name sortKey="Mohr, Amanda L A" sort="Mohr, Amanda L A" uniqKey="Mohr A" first="Amanda L A" last="Mohr">Amanda L A. Mohr</name>
</region>
<name sortKey="Talpins, Stephen K" sort="Talpins, Stephen K" uniqKey="Talpins S" first="Stephen K" last="Talpins">Stephen K. Talpins</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/WillowV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001149 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001149 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    WillowV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:24894458
   |texte=   Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24894458" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a WillowV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Nov 17 16:35:40 2020. Site generation: Tue Nov 17 16:39:32 2020